Skip to main content
TipRanks
Go Ultimate75% OFF

Daniel Mitchell Insider Profile

4 Followers

Daniel Mitchell, Director at Oruka Therapeutics, holds 611.00 shares in Oruka Therapeutics (Ticker: ORKA), holds 16.76K shares in GlobeImmune (Ticker: GBIM), holds 1.54M shares in Cardiovascular Systems (Ticker: CSII). Most recently, Daniel Mitchell Bought ― shares of Oruka Therapeutics on May 03, 2017 for an estimated value of $29.81K.

Daniel Mitchell's Trading History

ORKA
Oruka Therapeutics
May 03, 2017DirectorInformative Buy29.81K$64.37K
GBIM
GlobeImmune
Mar 18, 2016DirectorInformative Sell35.79K―
CSII
Cardiovascular Systems
―――$30.80M

You May Also Like

Daniel Mitchell insider profile FAQ

What is the percentage of profitable transactions made by Daniel Mitchell?
The percentage of profitable transactions made by Daniel Mitchell is 83%.
What is the average return per transaction made by Daniel Mitchell?
The average return per transaction made by Daniel Mitchell is 54.20%.
What stocks does Daniel Mitchell hold?
Daniel Mitchell holds: ORKA, GBIM, CSII stocks.
What was Daniel Mitchell’s latest transaction?
Daniel Mitchell’s latest transaction was an Informative Buy of $29.81K.
What was Daniel Mitchell's most profitable transaction?
Daniel Mitchell’s most profitable transaction was an Informative Sell of GBIM stock on February 23, 2016. The return on the trade was 89.50%.
What is Daniel Mitchell's role in Oruka Therapeutics?
Daniel Mitchell's role in Oruka Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.